Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

LEADING

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 13

FDA approve FROVATRIPTAN SUCCINATE

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 15

FDA approve MESALAMINE

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 7

FDA approve MONTELUKAST SODIUM

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 10

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

RUBICON

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 8

FDA approve GUANFACINE HYDROCHLORIDE

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 14

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 10

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 7

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 9

FDA approve ABACAVIR SULFATE; LAMIVUDINE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 13

FDA approve ESOMEPRAZOLE MAGNESIUM

Comment Full text
  • Previous
  • 35
  • 36
  • 37
  • 38
  • 39
  • Next

Search

News categories

  • Technical Exchange News(9316)
  • Event(407)
  • SEC News(151057)
  • FDA Approval(8679)
  • Company Report(721)
  • Business News(103719)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin